Loading...

383 posters, 2 videos, 1 audios, 8 topics, 28 sessions, 328 authors, 225 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

6556

CERVICAL SYMPATHETIC CHAIN BLOCK AT C5 TO SUCCESSFULLY TREAT REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME

Part of Topic

Medically Challenging Cases

Cervical Sympathetic Chain Block at C5 to Successfully Treat Reversible Cerebral Vasoconstriction Syndrome

Patrick LeFevre, Gabriel Sheena, Antoun Nader

Northwestern University

 

Introduction:

•The cervical sympathetic chain is responsible for sympathetic autonomic outflow
•We present a case in which this procedure, under ultrasound guidance, successfully treated reversible cerebral vasoconstriction syndrome (RCVS)
•

Materials and Methods

•Informed consent was obtained for submission of a case report

Case Report

•40-year-old male presented with headaches which progressed to neck pain, blurry vision, facial droop, and weakness
•Workup demonstrated cerebral artery vasospasm and newly reduced ejection fraction
•Calcium channel blockers and milrinone were only partially beneficial in restoring cerebral blood flow
 

Case Report (cont.)

•Acute pain team evaluated the patient for a stellate ganglion block
•Anomalous vertebral artery path at C6 prevented traditional administration
•Block placement at C5 as shown in Figure 1 resolved ipsilateral cerebral artery vasospasm for 24 hours as verified by transcranial doppler
 

Discussion

•There is growing evidence for treating RCVS via sympathetic blockade. Those occurring after subarachnoid hemorrhage have seen similar benefit in the literature
•Ultrasound guidance provides a safe, reproducible technique for block performance
•The role of regional anesthesia is ever expanding in tackling complex pathologies
asraspring2025 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.